BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 16246436)

  • 41. Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?
    Dela Peña I; Kim BN; Han DH; Kim Y; Cheong JH
    Arch Pharm Res; 2013 Apr; 36(4):400-10. PubMed ID: 23471559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment.
    Alburges ME; Hoonakker AJ; Horner KA; Fleckenstein AE; Hanson GR
    J Neurochem; 2011 May; 117(3):470-8. PubMed ID: 21323925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preadolescent methylphenidate versus cocaine treatment differ in the expression of cocaine-induced locomotor sensitization during adolescence and adulthood.
    Guerriero RM; Hayes MM; Dhaliwal SK; Ren JQ; Kosofsky BE
    Biol Psychiatry; 2006 Dec; 60(11):1171-80. PubMed ID: 16780809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic methylphenidate treatment during adolescence increases anxiety-related behaviors and ethanol drinking in adult spontaneously hypertensive rats.
    Vendruscolo LF; Izídio GS; Takahashi RN; Ramos A
    Behav Pharmacol; 2008 Feb; 19(1):21-7. PubMed ID: 18195591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
    Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
    Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
    Umehara M; Ago Y; Kawanai T; Fujita K; Hiramatsu N; Takuma K; Matsuda T
    Behav Pharmacol; 2013 Aug; 24(4):328-31. PubMed ID: 23751518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Algorithmically designed peptides ameliorate behavioral defects in animal model of ADHD by an allosteric mechanism.
    Kinkead B; Selz KA; Owens MJ; Mandell AJ
    J Neurosci Methods; 2006 Feb; 151(1):68-81. PubMed ID: 16423408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
    Leonard BE; McCartan D; White J; King DJ
    Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
    [No Abstract]   [Full Text] [Related]  

  • 49. Antidepressant treatment facilitates dopamine release and drug seeking behavior in a genetic animal model of depression.
    Roth-Deri I; Friedman A; Abraham L; Lax E; Flaumenhaft Y; Dikshtein Y; Yadid G
    Eur J Neurosci; 2009 Aug; 30(3):485-92. PubMed ID: 19614746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.
    Somkuwar SS; Kantak KM; Bardo MT; Dwoskin LP
    Pharmacol Biochem Behav; 2016 Feb; 141():66-77. PubMed ID: 26657171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD.
    Collins SL; Levin FR; Foltin RW; Kleber HD; Evans SM
    Drug Alcohol Depend; 2006 Apr; 82(2):158-67. PubMed ID: 16213109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopamine transporter density and behavioral response to methylphenidate in a hyperlocomotor rat model.
    Muneoka K; Kuwagata M; Iwata M; Shirayama Y; Ogawa T; Takigawa M
    Congenit Anom (Kyoto); 2006 Sep; 46(3):155-9. PubMed ID: 16922923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
    Han DH; Lee YS; Na C; Ahn JY; Chung US; Daniels MA; Haws CA; Renshaw PF
    Compr Psychiatry; 2009; 50(3):251-6. PubMed ID: 19374970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential sensitivity to the acute and sensitizing behavioral effects of methylphenidate as a function of strain in adolescent and young adult rats.
    Yetnikoff L; Arvanitogiannis A
    Behav Brain Funct; 2013 Oct; 9():38. PubMed ID: 24134881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cocaine effects on behavioral responding to a novel object placed in a familiar environment.
    Carey RJ; Damianopoulos EN; Shanahan AB
    Pharmacol Biochem Behav; 2008 Jan; 88(3):265-71. PubMed ID: 17897705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pay attention: ritalin acts much like cocaine.
    Vastag B
    JAMA; 2001 Aug 22-29; 286(8):905-6. PubMed ID: 11509035
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.
    Simchon Y; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):714-20. PubMed ID: 20493667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Region-specific elevation of D₁ receptor-mediated neurotransmission in the nucleus accumbens of SHR, a rat model of attention deficit/hyperactivity disorder.
    Ohno Y; Okano M; Masui A; Imaki J; Egawa M; Yoshihara C; Tatara A; Mizuguchi Y; Sasa M; Shimizu S
    Neuropharmacology; 2012 Sep; 63(4):547-54. PubMed ID: 22580374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic methylphenidate modulates locomotor activity and sensory evoked responses in the VTA and NAc of freely behaving rats.
    Yang PB; Swann AC; Dafny N
    Neuropharmacology; 2006 Sep; 51(3):546-56. PubMed ID: 16824558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monoamine and motor responses to cocaine are co-deficient in the Fawn-Hooded depressed animal model.
    Broderick PA; Hope O
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):887-98. PubMed ID: 16626846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.